Clinical Trials Directory

Trials / Completed

CompletedNCT07122349

Cannabis Impairment Detection Device Study

An Interventional Study to Facilitate the Development of a Cannabis Impairment Detection Device in Adult Cannabis Users

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
362 (actual)
Sponsor
Gaize · Industry
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to develop a cannabis impairment detection device in adult cannabis users. The main question\[s\] it aims to answer are: * Is the investigational device accurate and reliable at detecting cannabis impairment? * is the device safe for the collection of eye movement data from cannabis intoxicated individuals? Participants will be administered a series of Drug Recognition Expert Ocular Tests via the Gaize headset following cannabis consumption.

Conditions

Interventions

TypeNameDescription
DEVICECannabis Impairment TestAutomated Drug Recognition Expert Ocular Tests administered via VR Headset, includes test for Lack of Smooth Pursuit, Horizontal and Vertical Gaze Nystagmus, Lack of Convergence, and Pupillary Rebound Dilation. Tests are preceded by an automated system calibration process.

Timeline

Start date
2022-09-08
Primary completion
2022-10-24
Completion
2022-10-24
First posted
2025-08-14
Last updated
2025-08-17

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT07122349. Inclusion in this directory is not an endorsement.